{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-prevention-of-premature-destruction-of-records”
},
“headline”: “SOP for Prevention of Premature Destruction of Records”,
“description”: “This SOP establishes procedures for preventing premature destruction of clinical trial records, ensuring compliance with FDA, EMA, CDSCO, WHO, GDPR, HIPAA, and ICH GCP retention requirements. It includes secure storage, destruction authorization, and CAPA for deviations.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for Prevention of Premature Destruction of Records

Purpose

The purpose of this SOP is to establish controls that prevent the premature destruction of clinical trial records, ensuring that all documents are retained in accordance with global regulatory requirements. This protects subject rights, preserves data integrity, and maintains inspection readiness.

Scope

This SOP applies to sponsors, investigators, CROs, QA, and archival vendors managing Trial Master Files (TMFs), Investigator Site Files (ISFs), pharmacovigilance records, laboratory data, and all essential documents. It covers paper, electronic, and hybrid records.

Responsibilities

• Sponsor: Defines retention timelines and authorizes destruction after expiry.
• Investigator: Maintains site-level records and ensures no premature destruction.
• Archivist: Secures archives and prevents unauthorized disposal.
• QA: Audits archival systems and verifies compliance with regulatory timelines.
• Vendors: Require sponsor authorization before destruction of stored records.

Accountability

The Sponsor is accountable for defining and approving destruction timelines. QA is accountable for verifying compliance, investigating deviations, and ensuring corrective and preventive actions (CAPA).

Procedure

1. Retention Compliance
1.1 Retain records according to global regulations (FDA, EMA, CDSCO, WHO).
1.2 Retention timelines must be documented in Record Retention Log (Annexure-1).

2. Authorization for Destruction
2.1 No records may be destroyed without formal sponsor authorization.
2.2 Maintain Destruction Authorization Form (Annexure-2).
2.3 Both QA and Sponsor sign off before destruction occurs.

3. Vendor Oversight
3.1 Archival vendors must not destroy records without written approval.
3.2 Maintain Vendor Destruction Oversight Log (Annexure-3).

4. Electronic Records
4.1 eArchives must have system-based retention controls.
4.2 Implement access restrictions to prevent accidental deletion.
4.3 Perform quarterly backup verification.

5. Deviation Management
5.1 Record all premature destruction incidents in Destruction Deviation Log (Annexure-4).
5.2 Conduct root cause analysis and implement CAPA.

6. Training
6.1 Archivists and staff must be trained in retention policies.
6.2 Document training in Training Log (Annexure-5).

Abbreviations

• SOP: Standard Operating Procedure
• TMF: Trial Master File
• ISF: Investigator Site File
• QA: Quality Assurance
• CRO: Contract Research Organization
• CAPA: Corrective and Preventive Action
• GDPR: General Data Protection Regulation
• HIPAA: Health Insurance Portability and Accountability Act

Documents

1. Record Retention Log (Annexure-1)
2. Destruction Authorization Form (Annexure-2)
3. Vendor Destruction Oversight Log (Annexure-3)
4. Destruction Deviation Log (Annexure-4)
5. Training Log (Annexure-5)

References

• ICH E6(R2/R3) – Essential Document Retention
• FDA – Record Retention and Destruction Guidance
• EMA – Record Preservation Standards
• CDSCO – Record Retention Rules
• WHO – Clinical Trial Record Management

Version: 1.0

Approval Section

Annexures

Annexure-1: Record Retention Log

Annexure-2: Destruction Authorization Form

Annexure-3: Vendor Destruction Oversight Log

Annexure-4: Destruction Deviation Log

Annexure-5: Training Log

Revision History

For more SOPs visit: Pharma SOP